Abstract
Diabetic retinopathy (DR) is a retinal disease in patients with diabetes caused by metabolic disorders of glucose, and often leads to irreversible blindness if not treated properly. Dysfunction of retinal endothelial cells (RECs) contributes to the pathogenesis of DR. In the present study we investigated the apoptotic effect of high glucose concentration. High glucose was used to induce cell injury. LDH assay kit was used to detect the leakage of LDH. Western blot was used to detect the expression of bax, cleaved-caspase-3, bcl-2 and p53 proteins. The transmission electron microscope was used to observe apoptotic morphological changes. In the present study, we found that the LDH leakage ratio was significant increased after exposing to 30 mmol/L glucose for 12 h, and both showed a concentration-department manner and time dependent fashion. Next, obvious apoptotic morphological changes were observed after treating the cells with glucose at 30 mmol/L. Further research indicated that the protein levels of p53, pro-apoptotic cleaved-caspase-3, and bax were significantly upregulated, and the level of bcl-2 was decreased after treating with glucose at 30 mmol/L. The protein levels of bax and cl-caspase-3 were significantly decreased and the expression of bcl-2 was increased after pretreated with p53 specific inhibitor pifithrin-α. In conclusion, high glucose concentration induces apoptosis in retinal endothelial cells by activating p53 signaling pathway.
Keywords: Diabetic retinopathy, glucose, retinal endothelial cells, apoptosis, p53 signaling pathway
Introduction
Diabetes occurs in approximately 8.5% of adults aged 18 years and older, and caused 1.6 million deaths in 2014 [1,2]. Hyperglycemia can cause injury to the peripheral nerves, and the renal and vascular systems [3]. Diabetic retinopathy (DR), a common microvascular complication of diabetes, also is a leading cause of adult blindness [4]. Retinal edema is the major cause of visual impairment in patients with DR, and increased apoptosis occurs in many retinal cells including pigment epithelial cells, pericytes, and endothelial cells [5-7]. Although vitrectomy or laser photocoagulation is used for the treatment of DR, these approaches are not satisfactory [8-11]. Therefore, a novel and effective intervention approach is required to decrease retinal injury in patients with DR.
High glucose concentration plays a key role in retinal cell death [12,13]. Several lines of evidence have shown that high glucose induces the overproduction of pro-inflammatory cytokines such as TNF-α, and IL-1β, which act by a positive feedback mechanism to induce retinal cell apoptosis [14,15]. Apoptosis, a form of programmed cell death, can occur in a wide range of physiological and pathological situations. It is characterized by cell shrinkage, programmed DNA degradation, cytoplasmic cytochrome C release, and activation of caspases [16]. The abnormal release of lactate dehydrogenase (LDH) is an index of plasma membrane damage and cell apoptosis [17]. However, the pro-apoptotic effect of high glucose in retinal endothelial cells (RECs) is still unclear especially through regulate p53 signaling pathway. Hence, the aim of the present study was to investigate the apoptotic effect of high glucose in RECs which are involved in the p53 signaling pathway.
Materials and methods
Materials
RPMI 1640 Medium with glucose 5.6 mmol/L was purchased from Gibco (Grand Island, NY, USA). Fetal bovine serum (FBS) was from HyClone (Logan, UT, USA). p53 specific inhibitor pifithrin-α was obtained from Beyotime (Jiangsu, China). Rabbit polyclonal antibody to bax, bcl-2 and cleaved caspase-3 were provided by Cell Signaling Technology (Danvers, MA, USA). GAPDH antibodies were obtained from Abcam (Cambridge, MA, USA). p53 antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Relative second antibodies were from Beyotime (Jiangsu, China). BCA protein assay kit was from Kangchen Biotech (Shanghai, China).
Retinal endothelial cells culture and treatment
Retinal endothelial cell (REC) cell line was originally supplied by the American Type Culture Collection (Manassas VA, USA). The cells are certified as the designated type and have been checked free of contamination. Cells were cultured in the RPMI-1640 medium supplemented with 10% FBS, and 100 U/ml penicillin and streptomycin, and maintained at 37°C in a humidified atmosphere with 5% CO2. Before the experiments, cells were cultured in the RPMI-1640 medium with 1% FBS for 12 h, followed by the treatment of high glucose.
LDH assay
The RECs (1-1.5×106/mL) were exposed to different concentrations of glucose for 12 h, high glucose (30 mmol/L) or mannitol (24.4 mmol/L, an osmotic control) for 6, 12, 24 h. The measurement of LDH leakage was by an LDH activity assay kit (Beyotime, Jiangsu, China) according to the instruction of the kit. LDH leakage rate was expressed as the percentage of the total LDH activity, according to the equation as follow: % LDH release rate = (LDH activity in medium/total LDH activity) × %.
Transmission electron microscopy
To observe the extent of apoptosis induced by high glucose, the transmission electron microscope (TEM) was used to observe apoptotic morphological changes. The cells were cultured under the indicated treatment; then, cells were collected via centrifugation (800 rpm, 5 min), and washed with PBS and fixed in freshly prepared 1% paraformaldehyde and then with 2% glutaraldehyde for 24 h. Then, the fixed cells were treated with 1% osmium tetroxide for 3 h, dehydrated through an ethanol gradient, and embedded in araldite. Ultrathin sections were prepared, stained with uranyl acetate and lead citrate, and observed under a TEM (JEM-101, Jeol Electron Inc, Japan).
Western blot
The cells were washed once in PBS and lysed on ice in lysis buffer supplemented with protease inhibitor cocktail and phosphatase inhibitors (150 μL). The protein (40 μg) was loaded, separated by 10% SDS-PAGE, and blotted onto PVDF membrane (0.22 μm, GE Healthcare, Buckinghamshire, UK). The membrane was incubated with blocking buffer for 5 h at room temperature and then incubated overnight at 4°C with the primary polyclonal antibodies against p53 (1:900), bax (1:1200), caspase-3 (1:1000) and bcl-2 (1:1000), followed by incubation with corresponding secondary antibodies. Specific protein bands were visualized with an ECL advanced western blot analysis detection kit (Merck Millipore, Billerica, MA, USA).
Statistical analysis
Statistical analyses was performed by Graphpad Prism 6.0 (GraphPad Software, Inc. La Jolla, CA). All data are presented as means ± SEM. Steer-Dwass or Mann-Whitney multiple comparison tests were used to compare the differences among groups. A value of P < 0.05 was considered statistically significant.
Results
High glucose increases the leakage of LDH in retinal endothelial cells (RECs)
Cytotoxic compounds often impair the integrity of the cell membrane by inducing cell apoptosis or necrosis. LDH serves as a biomarker of cell membrane injury [18,19]. Figure 1A and 1B indicated that the LDH leakage ratio was significantly increased after exposing to 30 mmol/L glucose for 12 h, and both showed a concentration-department manner and time-dependent fashion. However, Figure 1C showed that the LDH leakage ratio was not altered after treated with mannitol for 0, 6, 12 or 24 h (24.4 mmol/L, an osmotic control). This result indicated that the leakage of LDH induced by high glucose was not a result of high osmolarity.
Figure 1.
High glucose concentration induces LDH release in retinal endothelial cells (RECs). A. Cells were treated with glucose (15, 30, 60 or 90 mmol/L) for 12 h; B. Cellswere treated with glucose at 30 mmol/L for 0, 6, 12 or 24 h; C. Cells were treated with mannitol at 24.4 mmol/L for 0, 6, 12 or 24 h. After the indicated treatment, LDH release was detected. Results were from three independent experiments and expressed as mean ± S.E.M. **P < 0.01 vs. control.
High glucose concentration induces cell apoptosis in RECs
Next, we explore whether a high glucose level induces cell apoptosis (programmed cell death). To address this question, we performed transmission electron microscopy to observe cellular morphology in great detail. TEM was able to clearly differentiate between nuclei and organelles, and thus confirm the occurrence of apoptosis in cells [20]. As shown in Figure 2 that obvious apoptotic morphological changes were observed after treating the cells with glucose at 30 mmol/L for 12 h. This typically included vacuolization in the mitochondria, chromatin condensation, and degranulation in the endoplasmic reticulum. However, when RECs were treated with mannitol at 24.4 mmol/L for 12 h, as an osmotic control, the changes were not shown. This result indicated that cell apoptosis induced by high glucose was not a result of high osmolarity.
Figure 2.
Effect of high glucose concentration on the morphological changes of RECs (20000×). Cells were incubated with glucose at 30 mmol/L for 12 h, then tapoptotic morphological change was observed by transmission electron microscope.
High glucose induces expression of cleaved-caspase-3, bax, and bcl-2 in RECs
In order to further explore the apoptotic mechanisms, the protein levels of pro-apoptotic cleaved-caspase-3, bax, and anti-apoptotic Bcl-2 were detected by western blot. As showed in Figure 3, the protein expression of Caspase-3, and bax in the high glucose group (30 mmol/L) were significantly upregulated compared with that of the control group (P < 0.01), and the level of bcl-2 was decreased after treating with glucose at 30 mmol/L for 12 h in RECs. However, when RECs were treated with mannitol at 24.4 mmol/L for 12 h, which is an osmotic control, it did not influence the related proteins. This result indicated that the cell apoptosis induced by high glucose was not a result of high osmolarity.
Figure 3.
High glucose concentration induces expression of cl-caspase-3, bax and bcl-2 in RECs. Cells were incubated with glucose at 30 mmol/L for 12 h, then each protein level was analyzed by western blot. Levels of protein are shown as fold change from control from 3 independent experiments and expressed as mean ± S.E.M. **P < 0.01 vs. control.
p53 signaling pathway involve in apoptotic effect of high glucose
As shown in Figure 4, p53 expression was increased after stimulation with glucose at 30 μmol/L for 12 h in RECs. However, exposing cells to mannitol at 24.4 μmol/L did not affect the level of the above proteins. This suggested that high glucose causing an increase in the expression of p53 was not a consequence of high osmolarity.
Figure 4.

p53 signaling pathway is involved in the apoptotic effect of high glucose concentration in RECs. The cells were subjected to high glucose at 30 μmol/L or mannitol at at 24.4 μmol/L for 12 h, then, expression of p53 were assayed by western blot. Results were from three independent experiments and data are expressed as mean ± S.E.M. **P < 0.01 vs. control.
Further research by western blot showed that bax and cl-caspase-3 proteins were significantly decreased and the expression of bcl-2 was increased after pretreated with p53 specific inhibitor pifithrin-α 10 μmol/L for 1 h. These results indicated that the p53 signaling pathway was involved in the apoptotic effect of high glucose in REC (Figure 5).
Figure 5.
p53 signaling pathway involved in high glucose concentration-induced expression of cl-caspase-3, bax and bcl-2 in RECs. Cells were pretreated with pifithrin-α 10 μmol/L for 1 h and then incubated with glucose at 30 mmol/L for 12 h. Each protein level was analyzed by western blot. Levels of protein are shown as fold change from control from 3 independent experiments and expressed as mean ± S.E.M.. **P < 0.01 vs. high glucose at 30 mmol/L.
Finally, we explored whether pretreatment with pifithrin-α, 10 μmol/L for 1 h, was able to inhibit high glucose-induced cell apoptosis. Figure 6 showed that the cells in high glucose at 30 mmol/L displayed obvious apoptotic morphological changes, and pre-treatment with specific pathway inhibitors significantly inhibited the apoptotic morphological changes in RECs.
Figure 6.
p53 signaling pathway involved in high glucose concentration-induced morphological changes of RECs (20000×). The cells were pretreated with pifithrin-α 10 μmol/L for 1 h and then incubated with glucose at 30 mmol/L for 12 h. Apoptotic morphological change was observed by transmission electron microscope.
Discussion
Hyperglycemia is the primary factor that contributes to retinal injury in the development of DR [3,13]. Retinal endothelial cells (RECs) play many important functions in the retina, including phagocytosis of photoreceptor outer segments, isomerization of retinoids, and various metabolic and neurotrophic support functions, and dysfunction of RECs contributes to the pathogenesis of DR [5,21,22]. High glucose increases the risk of cell damage and dysfunction in RECs [23]. Much work has demonstrated that RECs are an important cell type affected by diabetic retinopathy, and many others have demonstrated that high glucose increased the levels of apoptosis in REC [24-26]. The abnormal release of LDH is an index of plasma membrane damage and cell apoptosis. Consistent with these studies, we found that the LDH leakage ratio was significantly increased after exposure to 30 mmol/L glucose for 12 h, in both a concentration-dependent manner and time-dependent fashion. Next, obvious apoptotic morphological changes were observed after treated the cells with glucose at 30 mmol/L for 12 h. However, those phenomena were not altered after treated with mannitol.
Apoptosis occurs in a wide range of physiological and pathological situations. It is characterized by cell shrinkage, programmed DNA degradation, and activation of caspases. p53 plays a key role in DNA damage-induced apoptosis by affecting its transcriptional target pro-apoptotic bax, or translocates to the mitochondria to interact with anti-apoptotic bcl-2 in a non-transcriptional way [27,28]. The down-regulation of Bcl-2 and the up-regulation of Bax is able to induce the release of cytochrome-C (cytosol) from mitochondria, and then trigger the activity of caspase-3 to finally cause cell apoptosis [29,30]. Our data showed that the protein levels of pro-apoptotic cleaved-caspase-3 and bax were significantly upregulated and the level of bcl-2 was decreased after treatment with glucose at 30 mmol/L. Further study indicated that p53 expression was increased after stimulation with glucose at 30 μmol/L. However, cells exposure to mannitol at 24.4 μmol/L did not affect those proteins in RECs. Further research showed that bax and cl-caspase-3 proteins were significantly decreased and the expression of bcl-2 was increased after pretreatment with p53 specific inhibitor pifithrin-α. These results indicated that the p53 signaling pathway is involved in the apoptotic effect of high glucose in REC.
In conclusion, high glucose concentration was able to increase cell apoptosis of RECs, characterized by inducing plasma membrane damage as well as increasing the level of bax and caspase-3 and decreasing the expression of bcl-2. The above mechanism occurs mainly via activating the p53 pathway.
Disclosure of conflict of interest
None.
References
- 1.Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–2251. doi: 10.1016/S0140-6736(17)30058-2. [DOI] [PubMed] [Google Scholar]
- 2.Wen L, Duffy A. Factors influencing the gut microbiota, inflammation, and type 2 diabetes. J Nutr. 2017;147:1468S–1475S. doi: 10.3945/jn.116.240754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Li W, Yanoff M, Liu X, Ye X. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin Med J (Engl) 1997;110:659–663. [PubMed] [Google Scholar]
- 4.Yoon CH, Choi YE, Cha YR, Koh SJ, Choi JI, Kim TW, Woo SJ, Park YB, Chae IH, Kim HS. Diabetes-induced Jagged1 overexpression in endothelial cells causes retinal capillary regression in a murine model of diabetes mellitus: insights into diabetic retinopathy. Circulation. 2016;134:233–247. doi: 10.1161/CIRCULATIONAHA.116.014411. [DOI] [PubMed] [Google Scholar]
- 5.Knight BC, Brunton CL, Modi NC, Wallace GR, Stanford MR. The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J Neuroimmunol. 2005;160:41–47. doi: 10.1016/j.jneuroim.2004.10.023. [DOI] [PubMed] [Google Scholar]
- 6.Matsui A, Kaneko H, Kachi S, Ye F, Hwang SJ, Takayama K, Nagasaka Y, Sugita T, Terasaki H. Expression of vascular endothelial growth factor by retinal pigment epithelial cells induced by amyloid-beta is depressed by an endoplasmic reticulum stress inhibitor. Ophthalmic Res. 2015;55:37–44. doi: 10.1159/000440885. [DOI] [PubMed] [Google Scholar]
- 7.Byeon SH, Lee SC, Choi SH, Lee HK, Lee JH, Chu YK, Kwon OW. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt. Invest Ophthalmol Vis Sci. 2010;51:1190–1197. doi: 10.1167/iovs.09-4144. [DOI] [PubMed] [Google Scholar]
- 8.Kogo J, Shiono A, Sasaki H, Yomoda R, Jujo T, Kitaoka Y, Takagi H. Foveal microstructure analysis in eyes with diabetic macular edema treated with vitrectomy. Adv Ther. 2017;34:2139–2149. doi: 10.1007/s12325-017-0598-4. [DOI] [PubMed] [Google Scholar]
- 9.Ojha S, Balaji V, Sadek B, Rajesh M. Beneficial effects of phytochemicals in diabetic retinopathy: experimental and clinical evidence. Eur Rev Med Pharmacol Sci. 2017;21:2769–2783. [PubMed] [Google Scholar]
- 10.Turchetti P, Librando A, Angelucci F, Carlesimo SC, Migliorini R. Management of diabetic retinopathy and macular diabetic edema: guidelines “euretina 2017”. Clin Ter. 2017;168:E340–E343. doi: 10.7417/T.2017.2032. [DOI] [PubMed] [Google Scholar]
- 11.Wykoff CC, Chakravarthy U, Campochiaro PA, Bailey C, Green K, Cunha-Vaz J. Long-term effects of intravitreal 0.19 mg fluocinolone acetonide implant on progression and regression of diabetic retinopathy. Ophthalmology. 2017;124:440–449. doi: 10.1016/j.ophtha.2016.11.034. [DOI] [PubMed] [Google Scholar]
- 12.Trudeau K, Molina AJ, Guo W, Roy S. High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am J Pathol. 2010;177:447–455. doi: 10.2353/ajpath.2010.091029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yu Y, Yang L, Lv J, Huang X, Yi J, Pei C, Shao Y. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis. Int J Clin Exp Pathol. 2015;8:6807–6813. [PMC free article] [PubMed] [Google Scholar]
- 14.Capitao M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117:2443–2453. doi: 10.1002/jcb.25575. [DOI] [PubMed] [Google Scholar]
- 15.Abu El-Asrar AM, Struyf S, Mohammad G, Gouwy M, Rytinx P, Siddiquei MM, Hernandez C, Alam K, Mousa A, De Hertogh G, Opdenakker G, Simo R. Osteoprotegerin is a new regulator of inflammation and angiogenesis in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:3189–3201. doi: 10.1167/iovs.16-20993. [DOI] [PubMed] [Google Scholar]
- 16.Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov. 2017;16:273–284. doi: 10.1038/nrd.2016.253. [DOI] [PubMed] [Google Scholar]
- 17.Smith SM, Wunder MB, Norris DA, Shellman YG. A Simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One. 2011;6:e26908. doi: 10.1371/journal.pone.0026908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jantas-Skotniczna D, Kajta M, Lason W. Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal cultures. Brain Res. 2006;1069:145–153. doi: 10.1016/j.brainres.2005.11.055. [DOI] [PubMed] [Google Scholar]
- 19.Kajta M, Trotter A, Lason W, Beyer C. Effect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells. Brain Res Dev Brain Res. 2005;160:40–52. doi: 10.1016/j.devbrainres.2005.08.002. [DOI] [PubMed] [Google Scholar]
- 20.Shewring JR, Cankut AJ, McKenzie LK, Crowston BJ, Botchway SW, Weinstein JA, Edwards E, Ward MD. Multimodal probes: superresolution and transmission electron microscopy imaging of mitochondria, and oxygen mapping of cells, using small-molecule Ir(III) luminescent complexes. Inorg Chem. 2017;56:15259–15270. doi: 10.1021/acs.inorgchem.7b02633. [DOI] [PubMed] [Google Scholar]
- 21.De Cilla S, Farruggio S, Vujosevic S, Raina G, Filippini D, Gatti V, Clemente N, Mary D, Vezzola D, Casini G, Rossetti L, Grossini E. Anti-vascular endothelial growth factors protect retinal pigment epithelium cells against oxidation by modulating nitric oxide release and autophagy. Cell Physiol Biochem. 2017;42:1725–1738. doi: 10.1159/000479441. [DOI] [PubMed] [Google Scholar]
- 22.Zhao B, Smith G, Cai J, Ma A, Boulton M. Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2. Br J Ophthalmol. 2007;91:538–545. doi: 10.1136/bjo.2006.101543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wu H, Jiang C, Gan D, Liao Y, Ren H, Sun Z, Zhang M, Xu G. Different effects of low- and high-dose insulin on ROS production and VEGF expression in bovine retinal microvascular endothelial cells in the presence of high glucose. Graefes Arch Clin Exp Ophthalmol. 2011;249:1303–1310. doi: 10.1007/s00417-011-1677-x. [DOI] [PubMed] [Google Scholar]
- 24.Ye EA, Steinle JJ. miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions. Vision Res. 2017;139:15–22. doi: 10.1016/j.visres.2017.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hu J, Wang J, Leng X, Hu Y, Shen H, Song X. Heparanase mediates vascular endothelial growth factor gene transcription in high-glucose human retinal microvascular endothelial cells. Mol Vis. 2017;23:579–587. [PMC free article] [PubMed] [Google Scholar]
- 26.Delton-Vandenbroucke I, Grammas P, Anderson RE. Regulation of n-3 and n-6 fatty acid metabolism in retinal and cerebral microvascular endothelial cells by high glucose. J Neurochem. 1998;70:841–849. doi: 10.1046/j.1471-4159.1998.70020841.x. [DOI] [PubMed] [Google Scholar]
- 27.Bykov VJ, Issaeva N, Zache N, Shilov A, Hultcrantz M, Bergman J, Selivanova G, Wiman KG. Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs. J Biol Chem. 2017;292:19607. doi: 10.1074/jbc.AAC117.000815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25:104–113. doi: 10.1038/cdd.2017.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Antonsson B. Bax and other pro-apoptotic Bcl-2 family “killer-proteins” and their victim, the mitochondrion. Cell Tissue Res. 2001;306:347–361. doi: 10.1007/s00441-001-0472-0. [DOI] [PubMed] [Google Scholar]
- 30.Mooney SM, Miller MW. Expression of bcl-2, bar, and caspase-3 in the brain of the developing rat. Brain Res Dev Brain Res. 2000;123:103–117. doi: 10.1016/s0165-3806(00)00081-x. [DOI] [PubMed] [Google Scholar]





